Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are effective for obese patients with type 2 diabetes mellitus (T2DM) because they concomitantly target obesity and dysglycaemia. Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with T2DM, we determined the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuthbertson, Daniel J., Irwin, Andrew, Gardner, Chris J., Daousi, Christina, Purewal, Tej, Furlong, Niall, Goenka, Niru, Thomas, E. Louise, Adams, Valerie L., Pushpakom, Sudeep P., Pirmohamed, Munir, Kemp, Graham J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516516/
https://www.ncbi.nlm.nih.gov/pubmed/23236362
http://dx.doi.org/10.1371/journal.pone.0050117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3516516/
https://www.ncbi.nlm.nih.gov/pubmed/23236362
http://dx.doi.org/10.1371/journal.pone.0050117

Ejemplares similares